James  Lightman net worth and biography

James Lightman Biography and Net Worth

James A. Lightman serves as Senior Vice President, General Counsel and Secretary of the Company. Mr. Lightman joined Wright Medical Group, Inc. in December 2011 as Senior Vice President, General Counsel and Secretary. Prior to joining legacy Wright, Mr. Lightman served in various legal and executive positions with Bausch & Lomb Incorporated, a privately held supplier of eye health products. From February 2008 to November 2009, Mr. Lightman served as Vice President and Assistant General Counsel of Bausch & Lomb, and held the position of Vice President, Global Sales Operations until August 2011. From June 2007 to February 2008, he served as Vice President and General Counsel of Eyeonics, Inc. Prior to joining Eyeonics, Mr. Lightman served as Senior Vice President and General Counsel of IntraLase Corp. from February 2005 to April 2007.

How old is James Lightman?

Mr. Lightman is currently 62 years old. There are 9 older executives and no younger executives at Wright Medical Group. The oldest executive at Wright Medical Group is Mr. Robert J. Palmisano, Pres, CEO & Exec. Director, who is 75 years old. Learn More on James Lightman's age.

How do I contact James Lightman?

The corporate mailing address for Mr. Lightman and other Wright Medical Group executives is PRINS BERNHARDPLEIN 200, AMSTERDAM P7, 38117. Wright Medical Group can also be reached via phone at 31-20-521-4777 and via email at [email protected]. Learn More on James Lightman's contact information.

Has James Lightman been buying or selling shares of Wright Medical Group?

James Lightman has not been actively trading shares of Wright Medical Group during the past quarter. Most recently, James Lightman sold 1,526 shares of the business's stock in a transaction on Monday, August 17th. The shares were sold at an average price of $30.16, for a transaction totalling $46,024.16. Learn More on James Lightman's trading history.

Who are Wright Medical Group's active insiders?

Wright Medical Group's insider roster includes Kevin Cordell (EVP), Tim Lanier (Insider), James Lightman (SVP), and Jennifer Walker (SVP). Learn More on Wright Medical Group's active insiders.

James Lightman Insider Trading History at Wright Medical Group

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/17/2020Sell1,526$30.16$46,024.16View SEC Filing Icon  
11/15/2019Sell188,868$29.45$5,562,162.60View SEC Filing Icon  
8/16/2018Sell480$27.16$13,036.80View SEC Filing Icon  
See Full Table

James Lightman Buying and Selling Activity at Wright Medical Group

This chart shows James Lightman's buying and selling at Wright Medical Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Wright Medical Group Company Overview

Wright Medical Group logo
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. It also provides sports medicines and other products to mechanically repair tissue-to-tissue or tissue-to-bone injuries, as well as other ancillary products. The company offers its products to orthopedic, trauma, and podiatric surgeons. It markets and sells its products through direct sales representatives, independent sales agencies, direct sales offices, and distributors. The company was founded in 1999 and is headquartered in Amsterdam, the Netherlands.
Read More

Today's Range

Now: $29.98
Low: $29.98
High: $29.98

50 Day Range

MA: $30.23
Low: $29.98
High: $30.72

2 Week Range

Now: $29.98
Low: $23.14
High: $30.74

Volume

9,689 shs

Average Volume

2,015,203 shs

Market Capitalization

$3.90 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.57